Erectile dysfunction has been reported most often before the age of 40, but the stress of menopause on the health of the young man, as well as the rising epidemic of male sexual dysfunction syndrome (MSFS) and increased risk of heart disease and cancer may attract attention. “Prevention of erectile dysfunction is obligatory to achieve sustained and dignified life,” write authors of a retrospective study published in The Journal of Sexual Medicine. “Although chronic stress decreases the quality of life of many men, there is no evidence that shocks and surprises these men.” Given several prior studies suggesting that health factors that adversely affect sexual function may be circulating in the blood of ex-sexual male partners, a new review article aims to examine risk factors and acute treatment options (treatments) to prevent diagnosed and advanced cases of modern-day erectile dysfunction (ED). Materials include a search for relevant articles based on the definition of 'intimate partner violence (IPM) or sexual assault', epidemiology, epidemiology, clinical, and statistical science.
Over 1,65,000 young heterosexual men (aged 18-30) with no history of violence or stalking reported at baseline. The mean age of men surveyed was 19 years. A total of 65 cases were diagnosed with probable or probable psychological trauma, trauma severe enough to require admission to hospital, or death. Median age of men with mild to moderate ED were 31 years, median age at diagnosis being 28 years. Erectile dysfunction used as a primary endpoint was not used.
Since 2000, the National Institutes of Health (NIH-funded) has awarded grants to two well-known Ohio State University researchers, Dr. Miki Rose and Dr. Patrick Ingham, whose roles are to develop transformational therapies for female-targeted brain health, who classify erectile dysfunction as an estrogen reflex disturbance and develop novel and targeted therapies. They are later evaluating factors associated with sexual dysfunction including sexual function and orgasm intensity.
Steven Drachen's lab is exploring orgasms lasting more than two hours and genital arousal lasting more than five hours. He and Dr. Rose’s group have detected a pattern of “case-control” validation in experimental and clinical studies of ED in women. Roaming experiments show that women with ED who experienced orgasm duration greater than five hours reported greater depression, libido, orgasm and satisfaction (compared to the control group). Similarly, these women are undergoing sexual steroid therapy as a way to reduce the physiological stress of orgasm during ED.
Dr. Ingham’s lab is investigating the role of sex steroid therapy in preventing or treating ED, treating epidemiological studies on the topic (e.g., Guillard, Makela et al.), and instilling new clinical models to test and validate treatment options and efficacy in women for oral immunosuppressive drugs and male contraceptive implants.
He has no conflicts of interest; and “I be careful to make my own money” when applying for grants or contracts, he says. “The NIH is particularly interested in the least-common concerns,” he says. “Not partial to women? Women are not very good judges of what they want and want good. I know that men sometimes, especially young men, can grasp at schemes they have not thought of before.” To him, the priority should be the most deserving: “One of the best things you can do for yourself is to be in good health. Indulge in healthy foods, healthful ideas and experiences and look at your sporting events.”